Sun Pharma Advanced Research Company Ltd has informed that pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High court of Gujarat vide its order dated March 01, 2007 issued on March 28, 2007 and as per the Supplementary Trust Deed dated May 18, 2007, entered into by the Company with Sun Pharmaceutical Industries Ltd and Citicorp Trustee Co. Ltd, the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd (SPIL), are entitled to One Equity Share of Re 1/- each of the Company for every Equity Share of Rs 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of USD 1000 each held by them.
Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on December 29, 2007 has allotted 3,39,439 (Three Lakhs Thirty Nine Thousand Four Hundred and Thirty Nine) Equity Shares of Re 1/- each to the bondholders of SPIL upon exercise of option of conversion for 5,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them.
Consequently, the paid up Equity Share Capital of the Company has increased from 20,11,07,176 Equity Shares of Re 1/- each to 20,14,46,615 Equity Shares of Re 1/- each,as of date.
Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on December 29, 2007 has allotted 3,39,439 (Three Lakhs Thirty Nine Thousand Four Hundred and Thirty Nine) Equity Shares of Re 1/- each to the bondholders of SPIL upon exercise of option of conversion for 5,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them.
Consequently, the paid up Equity Share Capital of the Company has increased from 20,11,07,176 Equity Shares of Re 1/- each to 20,14,46,615 Equity Shares of Re 1/- each,as of date.
No comments:
Post a Comment